SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-23-000896
Filing Date
2023-04-18
Accepted
2023-04-18 17:18:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07609011_04182023.htm SC 13G 157499
2 JOINT FILING AGREEMENT ex991to13g07609011_04182023.htm EX-99.1 3580
  Complete submission text file 0000921895-23-000896.txt   162929
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 23827797
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853
Business Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853 212-230-3220
DIALECTIC CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001411512 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G